Groups
Company Size (Fulltime employees)
Looking for
Functionality
Headquartner in China
Biotech/Pharma Category
Biotech/Pharma Asset Stage
Medtech Category
Medtech Development Stage
Index
Countries
Reset

Bioxis Pharmaceuticals France

Bioxis, creates biomaterial scaffolds that help regenerate tissues, improve patient outcomes, and provide better healthcare opportunities for doctors. We are focused on developing medical devices based on patented biomaterials technology with potentially accelerated pathways to the aesthetic dermatology market.

Our lead medical device candidate MTI-12 is currently at the pre-clinical stage for aesthetic indications; and our hyaluronic acid-based dermal filler brand, CYTOSIAL, has established into exclusive distribution agreements with distributors in Europe and Asia.
Website:
www.bioxis.com
Company Size (Fulltime employees)
11-50
Year of foundation
2010
Looking for
Please specify your partnering goal
Chinese distributor for our Dermal Filler CYTOSIAL
Headquartner in China
No
Plan in China
CFDA completed for CYTOSIAL range of Dermal by Q1 2022.
Medtech Category
Medtech Information 1, Device Name|Description|Development Stage|Licensed Countries
CYTOSIAL|Dermal filler|Market authorization granted|
Medtech Development Stage
Frederic Bertaina
CEO 
Functionality
Management

Consulate General of Canada in Shanghai China

For more than 120 years, the Trade Commissioner Service (TCS) has been helping Canadian companies navigate international markets. Our trade commissioners in more than 160 cities worldwide can provide you with key business insights and access to an unbeatable network of international contacts. The TCS provides Canadian businesses and organizations with tailored advice to help them enter new markets outside of Canada.
Website:
https://www.tradecommissioner.gc.ca/about-a_propos/index.aspx?lang=eng
Year of foundation
1895
Looking for
Please specify your partnering goal
To expand Canadian life science innovation organizations and companies' access to China opporutnity and partnerships.
Headquartner in China
No
Plan in China
To promote and support above Canadian community's China IBD and partnership efforts and strategy on a sustainable basis.
Biotech/Pharma Category
Medtech Category
Lulu Mi
Life Sciences Trade Commissioner 
Functionality
Business Development

MedWorld Advisors United States

MedWorld Advisors is an international M&A Services Firm. We represent medical technology companies from the US, EU and Israel that want to enter the China market. We facilitate licensing, commercialization and acquisition deals between our clients and larger companies / investors in China. We are based in Boston in the U.S. We also have an operation in Hong Kong to help facilitate deals, as helpful.
Website:
www.medworldadvisors.com
Company Size (Fulltime employees)
1-10
Year of foundation
2015
Looking for
Please specify your partnering goal
We currently have 10 Medical Technology projects that may be interesting for the China market. We seek to meet appropriate China partners for these projects.
Headquartner in China
No
Plan in China
We have projects in medical imaging, image processing, endoscopy, endo-vascular, hemodynamics, oximetry, digital health, wearables, and wound care that may be interesting for the China market.
Medtech Category
Medtech Information 1, Device Name|Description|Development Stage|Licensed Countries
Multiple Projects|Open for Licensing / Acquisition|FDA Cleared|US, EU and Israel
Medtech Development Stage
Dave Sheppard
Managing Director 
Functionality
Business Development